UNIPHARMA ApS: Financial statements 2021
CVR: 78881917
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
UNIPHARMA ApS (CVR 78881917) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK -5,190 compared with DKK -5,000 the year before. Equity in the 2021 report amounted to DKK 56,545. The solvency ratio was 31.3%.
- Profit/Loss
- DKK -5,190
- Equity
- DKK 56,545
- Total Assets
- DKK 180,490
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | - | -5 t. | 57 t. | - |
| 2020 | -5 t. | -5 t. | -5 t. | 62 t. | - |
| 2019 | -5 t. | -5 t. | -5 t. | 67 t. | - |
| 2018 | -10 t. | -10 t. | -10 t. | 72 t. | - |
| 2017 | -9 t. | -9 t. | -9 t. | 73 t. | - |
Official annual report
Find more companies like UNIPHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
UNIPHARMA ApS has published its annual report for 2020. Revenue came to DKK -5,000, and the net result was DKK -5,000.
About UNIPHARMA ApS
UNIPHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 1985. The company is under bankruptcy. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company is owned by Ebba Dorrit Reumert. According to the 2023 annual report, the company had an average of 0 employees. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK -124,033.